Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2003
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030225042 Antipicornaviral compounds and compositions, their uses, and materials for their synthesis
12/04/2003US20030223941 Methods for modulating phototoxicity
12/04/2003CA2486644A1 Anilino liver x-receptor modulators
12/04/2003CA2486564A1 Acetamides and benzamides that are useful in treating sexual dysfunction
12/03/2003EP1366022A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
12/03/2003EP1082304B1 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)
12/03/2003EP0693072B1 Method for the synthesis of 4- and/or 5-(di)substituted 2-aminoimidazoles from 2-aminoimidazoles and aldehydes
12/03/2003CN1460103A Method of purifying N-(2-hydroxy ethyl)-2-pyrrolidone
12/03/2003CN1129604C Amino acid derivatives and their use as thrombin inhibitors
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/02/2003US6656964 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
11/2003
11/27/2003WO2003097600A1 Method for producing cyclic imides in the presence of polyphosphoric acid
11/27/2003WO2003097596A1 8-azaprostaglandin analogs as agents for lowering intraocular pressure
11/27/2003WO2003097595A1 Lactams used as anti-viral agents
11/27/2003WO2003097594A1 Process for preparing optically pure 3-hydroxy-pyrrolidine
11/27/2003WO2003097589A1 Method for the production of sulphamic acid halogenides
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003059881A3 Dna minor groove binding compounds
11/27/2003WO2003053354A3 Fused cyclic modulators of nuclear hormone receptor function
11/27/2003WO2003047417A3 Ep4 receptor agonist, compositions and methods thereof
11/27/2003WO2003037338A3 Modulators of the cholesterol biosynthetic pathway
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003US20030220517 Dechlorination in the presence of boron trifluoride; chemical intermediates for the synthesis of insecticides
11/27/2003US20030220506 A 7-(5-oxo-pyrrolidin-1-yl)-heptanoic acid or ester derivatives for therapeutic treatment of eye hypertension or glaucoma
11/27/2003US20030220493 Selectively inhibit binding to the alpha -1a adrenergic receptor; chemical intermediates
11/27/2003US20030220469 Novel compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same
11/27/2003US20030220400 Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
11/27/2003US20030220399 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia
11/27/2003US20030220386 Delta 1-pyrrolines for use as pesticides
11/27/2003US20030220353 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/27/2003US20030220352 Benzylated PDE4 inhibitors
11/27/2003US20030220339 Heterocyclic arylsulfonamidobenzylic compounds
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220320 Ningalin b analogs employable for reversing multidrug resistance
11/27/2003US20030220318 New phenylalanine derivatives
11/27/2003US20030220316 Such as N-(1-(1-methylethyl)piperidin-4-yl)-N-((4-methyl phenyl)methyl)-4-methoxyphenylacetamide for stimulation of serotonin receptors
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003CA2486148A1 Process for the preparation of cyclic imides in the presence of polyphosphoric acid
11/27/2003CA2485360A1 Method for the production of sulphamic acid halogenides
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003CA2483591A1 Lactams used as anti-viral agents
11/26/2003EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2003EP1363877A2 Benzophenones as inhibitors of reverse transcriptase
11/26/2003EP1363876A1 Glucocorticoid receptor modulators
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363623A2 Peptide deformylase inhibitors
11/26/2003EP1363621A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
11/26/2003EP0974572B1 Novel process for producing alcohols
11/26/2003EP0923546B1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
11/26/2003CN1458923A Substituted amino-aza-cycloalkanes useful against malaria
11/26/2003CN1458147A Process for synthesizing 5-keto-pyrrolidyl-3-carboxylic acid
11/26/2003CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors
11/25/2003US6653512 Halogen compounds such as heptafluoropropyl, chloromethyl ether, used as solvents, cleaning compounds, blowing agents, coolants, lubricants, in fire extinguishers or heat exchangers
11/25/2003US6653503 Microwave irradiation process for preparing methyl esters
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/25/2003CA2106370C Antibiotic compounds
11/25/2003CA2061168C The preparation and use of 3, (4)-substituted pyrrolidines as catalysts for the polyisocyanate polyaddition process
11/24/2003CA2387644A1 1,3-oxazolium-5-oxides or their alpha-amidoketene tautomers, process of preparation and uses thereof
11/20/2003WO2003095425A1 Cyanopyrrolidine derivatives
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003051276A3 Therapeutic heterocycles
11/20/2003WO2002102772B1 Methods of making pyrrolidones
11/20/2003WO2002032869A8 Substituted heterocyclic compounds for treating multidrug resistance
11/20/2003US20030216584 Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hemi-calcium essentially free of organic solvent
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216394 Etylene derivatives and pesticides containing said derivatives
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216380 Novel gamma secretase inhibitors
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030216260 Preparation by intramolecular cyclization
11/20/2003US20030215801 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
11/20/2003US20030215390 Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agent in mri imaging of joints
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/19/2003EP1362030A1 Novel benzoylguanidine salt
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361847A2 Bile-acid conjugates for providing sustained systemic concentrations of drugs
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003CN1128136C Synthesis method of idocifen
11/18/2003US6649717 Stabilized composition of O- and N-vinyl compounds and use of ammonium salts as stabilizers
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649656 Anticarcinogenic, antiallergen, antishock, and antiasthmatic agents
11/18/2003US6649642 Succinate derivative compounds useful as cysteine protease inhibitors
11/18/2003US6649639 Inhibit or block the biological activity of the picornaviral 3C protease.
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649623 Administering tetrahydropiperidine derivative; antidiabetic agents; hyperlipemia treatment; hypotensive agents
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/18/2003US6649603 For therapy of metabolic disorders related to insulin resistance or hyperglycemia
11/18/2003US6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/13/2003WO2003093254A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003093235A1 Carboxylic acid amides
11/13/2003WO2003093233A1 Process for the preparation of the amorphous form of atorvastatin calcium salt
1 ... 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 ... 404